CompaniesARTMSLatest from ARTMSMolecular ImagingTelix submits NDA for new prostate cancer imaging kitBy AuntMinnie.com staff writersTelix Pharmaceuticals has submitted a new drug application (NDA) to the U.S. FDA for a new PSMA-PET cold kit for prostate cancer imaging.May 28, 2024Molecular ImagingTelix to buy ARTMS in $82M dealBy AuntMinnie.com staff writersTelix Pharmaceuticals has entered an agreement to acquire Canadian diagnostic imaging isotopes company ARTMS for $82 million.March 6, 2024Radiation Oncology/TherapyNucleus RadioPharma appoints Mark Przekop as COOBy AuntMinnie.com staff writersNucleus RadioPharma has tapped Mark Przekop as its chief operating officer (COO) to lead supply chain strategy initiatives.December 7, 2023Nuclear MedicineNucleus RadioPharma forms to provide radiopharmaceuticalsBy AuntMinnie.com staff writersVenture capital firm Eclipse and the Mayo Clinic are creating and providing seed funding for a new company called Nucleus RadioPharma that aims to provide cancer patients access to therapeutic radiopharmaceuticals.October 11, 2022Nuclear MedicineARTMS seeks nod from Health Canada for Ga-68 productionBy AuntMinnie.com staff writersARTMS has submitted a drug master file to the Health Products and Food Branch of Health Canada for the production of gallium-68 (Ga-68).October 13, 2021Nuclear MedicineARTMS reports milestone in Ga-68 productionBy AuntMinnie.com staff writersARTMS has produced multiple curies of gallium-68 (Ga-68) after a two-hour bombardment on a U.S. cyclotron that has been used mainly for F-18 FDG production.May 24, 2021Nuclear MedicineARTMS seeks FDA nod to produce gallium-68By AuntMinnie.com staff writersARTMS has submitted a drug master file to the U.S. Food and Drug Administration (FDA) for multicurie production of the radioisotope gallium-68 using the company's technology and medical cyclotrons.March 30, 2021Molecular ImagingARTMS gets funds to develop Zr-89 for PETBy AuntMinnie.com staff writersCanadian radioisotope developer ARTMS has received $300,000 Canadian from Innovate BC to help develop the radioisotope zirconium-89 (Zr-89) for PET for patients who are eligible for immuno-oncology therapies.March 2, 2021Nuclear MedicineARTMS, Isotopia produce PSMA-11 in cyclotronBy AuntMinnie.com staff writersARTMS and Isotopia Molecular Imaging have announced the multicurie labeling of a prostate-specific membrane antigen (PSMA)-11-based radiopharmaceutical using cyclotrons.January 19, 2021Nuclear MedicineARTMS, Telix produce PSMA-11 in cyclotronBy AuntMinnie.com staff writersARTMS and Telix Pharmaceuticals this week announced a milestone in their relationship to produce a prostate-specific membrane antigen (PSMA)-11-based radiopharmaceutical using cyclotrons.January 11, 2021Nuclear MedicineARTMS Tc-99m gets green light from Health CanadaBy AuntMinnie.com staff writersMedical isotope developer ARTMS of British Columbia, Canada, announced that its cyclotron-produced technetium-99m (Tc-99m) radioisotope is being shipped commercially following approval on November 26 for clinical use by Health Canada.December 21, 2020Nuclear MedicineARTMS raises $19M in funding roundBy AuntMinnie.com staff writersMedical isotope developer ARTMS has raised $19 million in a series A round of financing with two investment funds.May 20, 2020Nuclear MedicineCompanies partner on gallium-68 imagingBy AuntMinnie.com staff writersARTMS Products and Telix Pharmaceuticals have signed a partnership covering the manufacturing of a radiopharmaceutical-based imaging agent based on the gallium-68 isotope.May 5, 2020Molecular ImagingImaginAb inks partnership with ARTMSBy AuntMinnie.com staff writersImaging agent developer ImaginAb has formed a strategic partnership with Canadian radioisotope production technology developer ARTMS Products.April 7, 2020Nuclear MedicineGE signs cyclotron partnership with Canadian firmBy AuntMinnie.com staff writersGE Healthcare and Canadian radioisotope production technology developer ARTMS Products have formed a strategic partnership to enhance the production and processing of radioisotopes on GE's PETtrace 800 series of medical cyclotrons.August 28, 2017
